AXL and acute myeloid leukemia: As discussed previously, studies have shown AXL overexpression and constitutive activation in AML cell lines and primary AML patient samples, and AXL has also been implicated in AML with acquired resistance to chemotherapy and/or targeted FLT3 inhibition.